Gene Expression and Metabolome Analysis Reveals Anti-Inflammatory Impacts of 11,17diHDoPE on PM10-Induced Mouse Lung Inflammation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105360 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Uijin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science & Engineering, Konkuk University, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Metabolome, Pneumonia, Particulate Matter, Anti-Inflammatory Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Oxylipins, the metabolites of polyunsaturated fatty acids, are vital in regulating cell proliferation and inflammation. Among these oxylipins, specialized pro-resolving mediators notably contribute to inflammation resolution. Previously, we showed that the specialized pro-resolving mediators isomer 11,17dihydroxy docosapentaenoic acid (11,17diHDoPE) can be synthesized in bacterial cells and exhibits anti-inflammatory effects in mammalian cells. This study investigates the in vivo impact of 11,17diHDoPE in mice exposed to particulate matter 10 (PM10). Our results indicate that 11,17diHDoPE significantly mitigates PM10-induced lung inflammation in mice, as evidenced by reduced pro-inflammatory cytokines and pulmonary inflammation-related gene expression. Metabolomic analysis reveals that 11,17diHDoPE modulates inflammation-related metabolites such as threonine, 2-keto gluconic acid, butanoic acid, and methyl oleate in lung tissues. In addition, 11,17diHDoPE upregulates the LA-derived oxylipin pathway and downregulates arachidonic acid- and docosahexaenoic acid-derived oxylipin pathways in serum. Correlation analyses between gene expression and metabolite changes suggest that 11,17diHDoPE alleviates inflammation by interfering with macrophage differentiation. These findings underscore the in vivo role of 11,17diHDoPE in reducing pulmonary inflammation, highlighting its potential as a therapeutic agent for respiratory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science & Engineering, Konkuk University, Seoul 05029, Republic of Korea.
- Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
ORCID-Profile: Uijin Kim, Dong-Hyuk Kim, Deok-Kun Oh, Ha Youn Shin
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, U., Kim, D. H., Oh, D. K., Shin, H. Y., & Lee, C. H. (2024). Gene Expression and Metabolome Analysis Reveals Anti-Inflammatory Impacts of 11,17diHDoPE on PM10-Induced Mouse Lung Inflammation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105360
Vancouver
Kim U, Kim DH, Oh DK, Shin HY, Lee CH. Gene Expression and Metabolome Analysis Reveals Anti-Inflammatory Impacts of 11,17diHDoPE on PM10-Induced Mouse Lung Inflammation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105360
BibTeX
@article{Kim2024,
author = {Kim, Uijin and Kim, Dong-Hyuk and Oh, Deok-Kun and Shin, Ha Youn and Lee, Choong Hwan},
title = {Gene Expression and Metabolome Analysis Reveals Anti-Inflammatory Impacts of 11,17diHDoPE on PM10-Induced Mouse Lung Inflammation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105360}
}
EUVIMED